Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on America Latina Times.
Press releases published on August 7, 2025
Volaris Reports July 2025 Traffic Results: Load Factor of 85%
GlobeNewswire
·
August 7, 2025
MEXICO CITY, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS and BMV: VOLAR) (“Volaris” or “the Company”), the ultra-low-cost carrier (ULCC) serving Mexico, the United States, Central and South America, …
LYNO AI Reports Strong Demand in Early Presale Stage with 176K+ Tokens Sold
GlobeNewswire
·
August 7, 2025
ROAD TOWN, British Virgin Islands, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The demand of LYNO AI is also growing, and it is fast attracting much attention in the decentralized finance field. The Early Bird presale phase of the project has already achieved an …
Blue Gold Adds Veteran Wall Street Financier & Fintech Innovator Jeremy Frommer to Advisory Board to Drive Tokenized Gold Strategy
GlobeNewswire
·
August 7, 2025
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Blue Gold Limited (Nasdaq: BGL) ("Blue Gold" or the “Company”), a next-generation gold development and technology company, today announced the appointment of Jeremy Frommer — a financier, fintech pioneer, and …
Soligenix Inc. (NASDAQ: SNGX) Proprietary Platform Aims to Meet Growing Need for Effective CTCL Therapy
GlobeNewswire
·
August 7, 2025
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Soligenix Inc. (NASDAQ: SNGX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork …
Quoin Pharmaceuticals Announces Second Quarter 2025 Financial Results and Corporate Update
GlobeNewswire
·
August 7, 2025
- Positive 6 Month Clinical Data Reported for Ongoing Pediatric Netherton Syndrome Study - FDA Clears Second Pivotal Study of QRX003 for Netherton Syndrome - Initial Positive Data Announced from Peeling Skin Syndrome Pediatric Study - Orphan Drug …
SELLAS Life Sciences Announces Independent Data Monitoring Committee Periodic Review and Positive Recommendation to Continue Pivotal Phase 3 REGAL Trial of GPS in AML Without Modification
GlobeNewswire
·
August 7, 2025
- Final Analysis Anticipated by Year-End Upon Occurrence of 80 Events - NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company …
Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies
GlobeNewswire
·
August 7, 2025
VERO BEACH, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies for cancer patients, today announced that it has secured a …
Full Alliance Group's Quant Blockchain Developing HIPAA-Compliant Healthcare Data Sharing Solution
GlobeNewswire
·
August 7, 2025
TAMPA, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group, Inc. (OTC: FAGI) announced today that its Qubitera Holdings subsidiary is developing breakthrough technology that will help hospitals and healthcare systems share patient information …
eToro Leverages AI to Redefine Social Investing
GlobeNewswire
·
August 7, 2025
AI-powered tools and APIs, enabling users to create AI powered strategies and dashboards. Open-garden marketplace will allow users to build, publish and access customized tools. AI Companion, Tori, answering questions, surfacing personalized insights and …
Back-to-School Reminder: Dr. Mayank Agarwal and Dr. Joshua Quinones Highlight the Importance of Early Heart Evaluations
EIN Presswire
·
August 7, 2025
Back-to-School Reminder: Dr. Mayank Agarwal and Dr. Joshua Quinones Highlight the Importance of Early Heart Evaluations on Great Day Houston HOUSTON, TX, UNITED STATES, August 6, 2025 /EINPresswire.com/ -- With the school year approaching, families are …
Barinthus Bio Reports Second Quarter 2025 Financial Results and Updates on Corporate Developments
GlobeNewswire
·
August 7, 2025
The final cohort of the single ascending dose (SAD) part of the Phase 1 AVALON trial initiated, with the SAD data readout expected early in the fourth quarter of 2025; The multiple ascending dose (MAD) part of the AVALON trial initiated; Available …
UroGen Pharma Expands Commercial Portfolio with Launch of ZUSDURI™ and Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
ZUSDURI™ (mitomycin) for intravesical solution now available as the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC) JELMYTO® achieved net product sales of $24.2 …
Replimune Reports Fiscal First Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 7, 2025
WOBURN, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced financial results for the fiscal first quarter …
Maxus Mining Initiates 2025 Exploration Program on the Penny Copper Project, British Columbia
GlobeNewswire
·
August 7, 2025
VANCOUVER, British Columbia, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Maxus Mining Inc. (“Maxus” or the “Company”) (CSE: MAXM | FRA: R7V), is pleased to announce the commencement of the Company’s 2025 exploration program (the “Program”) on its Penny Copper …
Critical Metals Corp Engages Global Engineering Firm NIRAS to Finalize DFS for Tanbreez in Greenland
GlobeNewswire
·
August 7, 2025
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Critical Metals Corp (NASDAQ: CRML) (“the Company”), a leading critical minerals mining company, is pleased to announce that Tanbreez Mining Greenland A/S (“Tanbreez”), has appointed NIRAS A/S (“NIRAS”), a …
Bitget Protection Fund Reaches Record High of $779.7M in July 2025, Reinforcing Commitment to User Asset Safety
GlobeNewswire
·
August 7, 2025
VICTORIA, Seychelles, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bitget, the leading cryptocurrency exchange and Web3 company, today released its July 2025 Protection Fund Report, revealing a new peak in valuation and underlining its steadfast commitment to …
Bitget Wallet Launches USD-Based Crypto Card in Brazil, Eye Latin America Expansion
GlobeNewswire
·
August 7, 2025
SAN SALVADOR, El Salvador, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bitget Wallet, the leading non-custodial crypto wallet, has launched its USD-based, zero-fee Mastercard crypto payment card in Brazil, marking its entry into Latin America's fast-growing digital …
Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar
GlobeNewswire
·
August 7, 2025
Vancouver, Canada, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
InflaRx Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 7, 2025
INF904 Phase 2a data in chronic spontaneous urticaria (CSU) and hidradenitis suppurativa (HS) expected by the end of September to early November 2025 Phase 1/2 data announced by Staidson BioPharmaceuticals for InflaRx-partnered C5a antibody BDB-001 in ANCA …
Y-mAbs to Announce Second Quarter 2025 Financial and Operating Results on August 8, 2025
GlobeNewswire
·
August 7, 2025
PRINCETON, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of antibody-based therapeutics for the …